| Target Price | A$3.26 |
| Price | A$3.10 |
| Potential |
5.29%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Sigma Pharmaceuticals 2026 .
The average Sigma Pharmaceuticals target price is A$3.26.
This is
5.29%
register free of charge
A$3.57
15.16%
register free of charge
A$2.53
18.55%
register free of charge
|
|
| A rating was issued by 14 analysts: 9 Analysts recommend Sigma Pharmaceuticals to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sigma Pharmaceuticals stock has an average upside potential 2026 of
5.29%
register free of charge
|
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion A$ | 6.00 | 10.08 |
| 21.85% | 67.93% | |
| EBITDA Margin | 0.79% | 11.45% |
| 17.93% | 1,347.67% | |
| Net Margin | 8.83% | 7.32% |
| 3,242.29% | 17.09% |
10 Analysts have issued a sales forecast Sigma Pharmaceuticals 2026 . The average Sigma Pharmaceuticals sales estimate is
This results in the following potential growth metrics:
9 Sigma Pharmaceuticals Analysts have issued a net profit forecast 2026. The average Sigma Pharmaceuticals net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 0.05 | 0.06 |
| 600.00% | 20.00% | |
| P/E | 48.34 | |
| EV/Sales | 3.74 |
9 Analysts have issued a Sigma Pharmaceuticals forecast for earnings per share. The average Sigma Pharmaceuticals EPS is
This results in the following potential growth metrics and future valuations:
Sigma Pharmaceuticals...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| ORD MINNETT |
Locked
➜
Locked
|
Locked | May 28 2025 |
| ORD MINNETT |
Locked
➜
Locked
|
Locked | May 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Sep 04 2025 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Aug 27 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
ORD MINNETT:
Locked
➜
Locked
|
May 28 2025 |
|
Locked
ORD MINNETT:
Locked
➜
Locked
|
May 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


